Table 2.
Characteristics | COVID-related survival | Overall survival | |||||||
---|---|---|---|---|---|---|---|---|---|
HR (95% CI) | P | AHR (95% CI) | P | HR (95% CI) | P | AHR (95% CI) | P | ||
Age, years | 1.18 (1.13–1.24) | <0.001 | 1.17 (1.11–1.23) | <0.001 | 1.18 (1.13–1.23) | <0.001 | 1.17 (1.12–1.23) | <0.001 | |
Male (vs. female) | 2.96 (1.56–5.63) | 0.001 | 1.79 (0.93–3.45) | 0.082 | 2.40 (1.39–4.16) | 0.002 | 1.48 (0.85–2.60) | 0.168 | |
White (vs. others) | 2.40 (0.33–17.41) | 0.385 | 0.89 (0.12–6.63) | 0.908 | 1.69 (0.41–6.95) | 0.465 | 0.68 (0.16–2.88) | 0.601 | |
Ever smoke (vs. never) | 2.90 (1.56–5.39) | 0.001 | 1.71 (0.88–3.34) | 0.113 | 2.43 (1.42–4.15) | 0.001 | 1.41 (0.79–2.50) | 0.245 | |
Comorbidity Index† | 1.43 (1.28–1.59) | <0.001 | 1.25 (1.09–1.44) | 0.001 | 1.41 (1.27–1.55) | <0.001 | 1.23 (1.08–1.39) | 0.002 | |
Ever taken cannabis (vs. others) | Any times | 0.50 (0.23–1.12) | 0.092 | 0.87 (0.38–2.02) | 0.753 | 0.52 (0.26–1.05) | 0.068 | 0.89 (0.42–1.86) | 0.749 |
≥3 times | 0.69 (0.27–1.73) | 0.426 | 1.58 (0.60–4.16) | 0.357 | 0.54 (0.22–1.36) | 0.191 | 1.17 (0.45–3.02) | 0.750 | |
≥1/month‡ | 1.28 (0.51–3.24) | 0.598 | 2.81 (1.04–7.59) | 0.041 | 1.00 (0.40–2.49) | 0.993 | 1.93 (0.73–5.08) | 0.185 |
HR, hazard ratio; 95% CI, 95% confidence interval; AHR, adjusted hazard ratio.
†Charlson-Quan Comorbidity Index was calculated by summing all the weights (from 1 to 6) of each comorbidity category based on inpatient ICD-10 records.
‡Maximum frequency of taking cannabis.